Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin for hypervolemic hyponatremia in decompensated cirrhosis
2019-000302-29Phase 2Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of albumin (human) in hyponatraemia, sponsored by Fundació Clínic per a la Recerca Biomèdica. Primary endpoint: Resolution of hyponatremia. Started Apr 2019; status: completed.
02
Drugs
albumin (human)
03
Conditions
hyponatraemia
Beyond the preview
Go deeper on 2019-000302-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000302-29.